Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease
W Herrington, B Lacey, P Sherliker, J Armitage… - Circulation …, 2016 - Am Heart Assoc
Atherosclerosis is a leading cause of vascular disease worldwide. Its major clinical
manifestations include ischemic heart disease, ischemic stroke, and peripheral arterial …
manifestations include ischemic heart disease, ischemic stroke, and peripheral arterial …
[HTML][HTML] Diabetes and peripheral artery disease: A review
Peripheral arterial disease (PAD) refers to partial or complete occlusion of the peripheral
vessels of the upper and lower limbs. It usually occurs as part of systemic atherosclerosis in …
vessels of the upper and lower limbs. It usually occurs as part of systemic atherosclerosis in …
[HTML][HTML] Diretrizes brasileiras de hipertensão arterial–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
A hipertensão arterial (HA) é uma doença crônica não transmissível (DCNT) definida por
níveis pressóricos, em que os benefícios do tratamento (não medicamentoso e/ou …
níveis pressóricos, em que os benefícios do tratamento (não medicamentoso e/ou …
Brazilian guidelines of hypertension–2020
WKS Barroso, CIS Rodrigues, LA Bortolotto… - Arquivos brasileiros de …, 2021 - SciELO Brasil
SciELO - Brasil - Diretrizes Brasileiras de Hipertensão Arterial – 2020 Diretrizes Brasileiras de
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
Hipertensão Arterial – 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos …
[HTML][HTML] Global vascular guidelines on the management of chronic limb-threatening ischemia
Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …
[HTML][HTML] Editor's choice--European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral …
J Nordanstig, CA Behrendt, I Baumgartner… - European Journal of …, 2024 - Elsevier
BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
JL Steegmann, M Baccarani, M Breccia, LF Casado… - Leukemia, 2016 - nature.com
Most reports on chronic myeloid leukaemia (CML) treatment with tyrosine kinase inhibitors
(TKIs) focus on efficacy, particularly on molecular response and outcome. In contrast …
(TKIs) focus on efficacy, particularly on molecular response and outcome. In contrast …
Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence
H Reinecke, M Unrath, E Freisinger… - European heart …, 2015 - academic.oup.com
Aims Only few and historic studies reported a bad prognosis of peripheral arterial disease
(PAD) and critical limb ischaemia (CLI). The contemporary state of treatment and outcomes …
(PAD) and critical limb ischaemia (CLI). The contemporary state of treatment and outcomes …
ESTES guidelines: acute mesenteric ischaemia
JVT Tilsed, A Casamassima, H Kurihara… - European Journal of …, 2016 - Springer
Purpose Acute mesenteric ischaemia (AMI) accounts for about 1: 1000 acute hospital
admissions. Untreated, AMI will cause mesenteric infarction, intestinal necrosis, an …
admissions. Untreated, AMI will cause mesenteric infarction, intestinal necrosis, an …
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and …
C Rosendorff, DT Lackland, M Allison, WS Aronow… - Circulation, 2015 - Am Heart Assoc
(AHA) scientific statement “Treatment of Hypertension in the Prevention and Management of
Ischemic Heart Disease: A Scientific Statement From the American Heart Association …
Ischemic Heart Disease: A Scientific Statement From the American Heart Association …